IMV Technologies completes the acquisition of Tecnovet, SL.


Media contact:

Angela De Mirjyn

Office: +1 763 488 1881

L’Aigle, France, December 21, 2020.- IMV Technologies has successfully completed the acquisition of Tecnovet, SL, a Spanish company specialized in swine artificial insemination technology and other veterinary products.  Tecnovet is recognized worldwide for its Import-vet line of swine insemination products. 

Tecnovet, SL, strengthens IMV Technologies’ position in the highly competitive market of swine insemination, and especially in post cervical artificial insemination (PCAI) technology.  “Juan Morell Bras and the expert team at Tecnovet are the demonstrated leaders swine artificial insemination products and service in Spain,” comments Alain de Lambilly, CEO of IMV Technologies.  “Like IMV Technologies’, their products have global reach, with important customers and partners across Europe, the United States, Russia and Latin America.

"Together, we will capitalize on our groups’ shared culture and strengths.  We share robust research and development programs, strong technical expertise, and a culture of quality and customer-service.” Alain de Lambilly continues.   “Tecnovet and IMV Technologies, through their developments and technology also share deep commitment toward sustainable animal agriculture.”

Tecnovet, previously also known as Import-Vet, was founded in 1991 by Juan Morell Bras.  His company has brought to market products that are used daily in boar semen production centers, such as the MetroSperm® device to calculate sperm concentration.   Other Tecnovet leading technologies include the Soft&Quick® line of cervical and post cervical insemination catheters; and its accompanying bulk semen deposition technology. 

As part of the IMV Technologies family, Tecnovet will enjoy access to the IMV distribution network, in more than 120 countries.   Innovation, science and technology products will have global exposure and leverage.

Juan Morell Bras, founder and CEO of Tecnovet, will continue to lead the team through the transition and beyond. “I am pleased to welcome Juan to the IMV Technologies group,” says Alain de Lambilly.  “Tecnovet’s success is in great measure due to his passion and expertise. Tecnovet’s valued customers and partners can rest assured that he and his team will continue to foster the business relationships and successes they have created together.”

About IMV Technologies

IMV Technologies is the world leader in assisted reproduction biotechnologies.  Founded in 1963, IMV Technologies, a French group, has subsidiaries and/or manufacturing facilities in Brazil, China, France, India, the Netherlands, Russia, Scotland, South Africa and the USA.  IMV Technologies’ family of companies operate leading brands in the areas of semen analysis, assisted reproduction, artificial insemination and veterinary imaging. Its Life Sciences division, Cryo Bio System, specializes in biobanking of high value samples and human assisted reproduction technologies. For more information, refer to